Increased serum concentrations of growth factor receptors and Neu in workers previously exposed to asbestos

Occupational and Environmental Medicine

Volumn 56, Issue 2, 1999, Pages 114-117

  Lahat, Nitza ^c   Froom, Paul ^a,b   Kristal Boneh, Estela ^a,b   Cohen, Chaim ^a,b   Lerman, Yehuda ^a,b   Ribak, Joseph ^a,b  

^a Occupational Health and Rehabilitation Institute Israel   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

Asbestos exposure; Growth factor receptors; Pleural plaques

Indexed keywords

ASBESTOS; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; ONCOGENE NEU; PLEURA PLAQUE; PRIORITY JOURNAL; RETIREMENT; RISK FACTOR; SMOKING; TIME;

EID: 0032942372     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.56.2.114     Document Type: Article

References (20)

1. Ulrich AI, Coussens L, Hayflick JS, et al. Human epidermal growth receptor eDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984;309:418-25.
2. Downward J, Yarden Y, Mages E, et al. Close similarity of EGF-R and V-erbB oncogene protein sequences. Nature 1984;307:521-7.
3. McKenzic SJ. Diagnosis utility of oncogenes and their products in human cancer. Biochim Biophys Acta 1991;1072:193-24.
4. Aaronson SA. Growth factors and cancer. Science 1991;254: 1146-53.
5. Zanella CI, Posada J, Tritton TR, et al. Asbestos causes stimulation of the extracellular signal regulated kinase 1 mitogen activated proteinase kinase cascade after phosphorylation of the EGF receptors. Cancer Res 1996;65:5334-8.
6. 11FRJ causes transformation and tumorigenesis in NIH 3T3 cells. Proc Natl Acad Sci USA 1987;84:7159-63.
7. Di Fiore PP, Pierce JH, Kraus MH, et al. erbB-2 is a potent oncogene when over expressed in N1H/3T3 cells. Science 1987;237:178-82.
8. Muller WJ, Sinn E, Pattengale PK, et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-Neu oncogene. Cell 1988;54:105-15.
9. McCann AH, Dervan PA, O'Regan M, et al. Prognostic significance of C-erbB-2 and estrogen receptor status in human breast cancer. Cancer Res 1991;51:3296-303.
10. Langton BC, Crenshaw MC, Chao IA, et al. An antigen immunologically related to the external domain of GP185 is shed from nude mouse tumors overexpressing the C-erbB-2 oncogene. Cancer Res 1991;51:2593-8.
11. Hages DF, Carney W, Tondini C, et al. Elevated circulatory c-Neu oncogene product in patients with breast cancer. Breast Cancer Treat 1989;14:135.
12. Dazzi H, Hasleton PS, Thatcher N, et al. Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4 monoclonal antibody. Br J Cancer 1990;61:924-6.
13. Kayser K, Weisse G, Gabius HJ, et al. Biotinylated epidermal growth factor: a useful tool for the histochemical analysis of specific binding sites. Histochem J 1990;22:426-32.
14. Ramael M, Segers K, Buysse C, et al. Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium. Virchows Archiv, A Pathological Anatomy 1991;419:171-5.
15. Lauber B, Leuchthold M, Schmitter D, et al. An autocrine mitogenic activity produced by a pleural human mesothelioma cell line. Int J Cancer 1992;50:943-50.
16. Lauber B, Schmitter D, Stahel RA. Human mesothelioma cell lines and mitogenic activity. Eur Respir Rev 1993;3:163-6.
17. Brandt-Rauf PW, Smith S, Hemminski K, et al. Serum oncoprotein and growth factors in asbestosis and silicosis patients. Int J Cancer 1992;50:881-5.
18. Brandt-Rauf PW, Luo JC, Carney WP, et al. Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans. Int J Cancer 1994;56:383-6.
19. Partanen R, Hemminski K, Brandt-Rauf P, et al. Serum level of growth factor receptors, EGFR and Neu in asbestos patients: a follow-up study. International Journal of Oncology 1994;4:1025-8.
20. Waterfield MP, Mayes ELV, Stoobant P, et al. Monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 1982;20:149-61.